Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$85.79 -2.47 | -2.8%
02/11/16 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 88.26
52 Week High 114.00
52 Week Low 54.92
Avg. Daily Vol. (Mil) 0.38
Beta (3 year) 0.91
Share Related Items
Mkt Cap (Mil) 1,758.65
Shares Out (Mil) 19.93
Float (Mil) 15.49
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 12.30
Current Ratio 12.90
LT Debt/ Equity 0.69
Total Debt / Equity 0.69
Valuation Ratios
Price Earnings 7.40
Price/Sales 23.86
Price/Book 6.02
Price/Cash Flow 6.60
Per Share Data
Earnings 11.94
Sales 3.70
Book Value 14.66
Cash Flow 13.35
Business Summary
Ligand Pharmaceuticals Inc is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure.
General Information
11119 North Torrey Pines Roa
Suite 200
La Jolla, CA 92037
www.ligand.com
Industry : Drugs
Sector: Health Care
Employees: 19
CEO: Mr. John L. Higgins
Short Interest
Current Month (Mil) 4.37
Previous Month (Mil) 4.18
Short Interest Ratio (Days) 9.50
Management Effectiveness
Return on Equity 86.70
Return on Assets 48.50
Return on Investments 51.10
Profitability
Gross Margin 87.90
EBIT Margin 48.20
Profit Margin 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter